土耳其同胞为主1型糖尿病一级亲属儿童自身抗体筛查:患病率、决定因素及筛查后亲子焦虑的多中心研究
该多中心横断面研究在土耳其9个儿科内分泌中心筛查了440名2–18岁1型糖尿病一级亲属,自身抗体阳性率为16.4%,ZnT8A最常见且随年龄下降。 gestational age每增加一周与自身抗体阳性风险降低独立相关。结果告知后,阳性儿童及家长焦虑显著增加,阴性者降低。
要点
- 一级亲属儿童自身抗体阳性率16.4%,ZnT8A最常见(11.4%)且在2–6岁占优势。
- gestational age每增加一周,自身抗体阳性风险降低(校正OR 0.80)。
- 筛查结果告知后焦虑反应因结果而异,需配对结果特异性心理支持。
核心结论
- ZnT8A在幼儿期占优势及 gestational age与自身抗体阳性的独立关联支持将年龄和围产史纳入症状前风险分层。
- 筛查结果告知后亲子焦虑呈结果依赖性变化,筛查项目应配对结构化的结果特异性咨询和心理支持。
研究设计与样本
- 多中心横断面研究,纳入土耳其9个儿科内分泌中心的440名2–18岁1型糖尿病一级亲属。
- 一级亲属关系包括姐妹(n=206)、兄弟(n=204)、母亲(n=22)和父亲(n=13)。
- 采用ELISA检测ZnT8A、GADA、IAA和IA-2A自身抗体,并记录围产期变量包括 gestational age。
- 在8–18岁亚组中,使用SCARED评估儿童焦虑,使用STAI-I/II评估父母焦虑,分别在筛查前和结果告知后立即进行。
主要发现
- 自身抗体阳性比例为16.4%(72/440),13人(3.0%)检测到多种自身抗体。
- 445个一级亲属关系中,92.1%为同胞关系,7.9%为亲子关系。
- ZnT8A是最常见的自身抗体(11.4%),在2–6岁儿童中占自身抗体阳性者的82%,并随年龄下降。
- ZnT8A阳性者显著年轻于ZnT8A阴性者(7.92 ± 4.62 vs 10.00 ± 4.54岁;p=0.002)。
- gestational age每增加一周与自身抗体阳性风险降低相关(校正OR 0.80/周;95% CI 0.68, 0.93;p=0.005),排除母亲患病者后关联持续且增强(校正OR 0.71/周;95% CI 0.59, 0.85;p<0.001)。
关键数值与推荐
- 自身抗体阳性定义为ELISA检测ZnT8A、GADA、IAA或IA-2A任一阳性。
- 多种自身抗体阳性定义为检测到一种以上自身抗体。
- 焦虑评估工具:8–18岁儿童使用完整SCARED,父母使用STAI-I/II。
临床怎么用
- 对1型糖尿病一级亲属儿童筛查时,应将年龄和围产史(尤其是 gestational age)纳入症状前风险分层。
- 筛查项目应配对结构化的、结果特异性的咨询,并整合针对亲子差异化焦虑反应的心理支持方案。
- 儿童焦虑评估应采用适合儿童的评估工具。
局限性
- 研究结果主要应在以同胞为主的儿科一级亲属筛查队列背景下解读。
- 横断面设计无法确定因果关系。
- 焦虑评估仅局限于8–18岁亚组。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/OBJECTIVE: We screened 2-18-year-old first-degree relatives (FDRs) of individuals with type 1 diabetes in Turkey for diabetes-associated autoantibodies to define their prevalence and age distribution, to identify determinants of autoantibody positivity, and to quantify acute anxiety changes in children and parents after result disclosure. METHODS: In this multicentre cross-sectional study conducted across nine paediatric endocrinology centres in Turkey, 440 FDRs aged 2-18 years were screened. Affected FDR relationships included an affected sister (n=206), brother (n=204), mother (n=22) and father (n=13). ZnT8A, GADA, IAA and IA-2A autoantibodies were measured by ELISA; perinatal variables including gestational age were recorded. In the 8-18-year-old subsample, child anxiety was assessed using the full Screen for Child Anxiety Related Emotional Disorders (SCARED) and parental anxiety for these children was assessed using the State-Trait Anxiety Inventory (STAI-I/II), administered before screening and immediately after disclosure. RESULTS: The proportion of participants who were autoantibody-positive was 16.4% (72/440), and multiple autoantibodies were detected in 13 individuals (3.0%). Among 445 affected FDR relationships, 92.1% were sibling-based and 7.9% were parent-based. ZnT8A was the most common autoantibody (11.4%) and predominated at ages 2-6 years (82% of autoantibody-positive children), declining with age. ZnT8A positivity showed an age-dependent decline, with ZnT8A-positive participants being significantly younger than ZnT8A-negative participants (7.92 ± 4.62 vs 10.00 ± 4.54 years; p=0.002). Each additional week of gestational age was associated with lower odds of autoantibody positivity (adjusted OR 0.80 per week; 95% CI 0.68, 0.93; p=0.005). This association persisted and was strengthened after exclusion of participants with an affected mother (adjusted OR 0.71 per week; 95% CI 0.59, 0.85; p<0.001). SCARED scores increased after disclosure in autoantibody-positive children (d=1.31; p<0.001) but decreased in autoantibody-negative children (d=0.62; p<0.001). Parental anxiety increased after positive results (state d=2.19; p<0.001; trait d=0.69; p=0.001) and decreased after negative results (p<0.001). CONCLUSIONS/INTERPRETATION: The ZnT8A predominance in early childhood and the independent association of gestational age with autoantibody positivity support integrating age and perinatal history into presymptomatic risk stratification. These findings should be interpreted primarily within the context of a sibling-dominant paediatric FDR screening cohort. The marked outcome-dependent anxiety response indicates that screening programmes should pair immunological testing with structured, result-specific counselling, integrating psychological support protocols that address differential parent-child anxiety responses with child-appropriate assessment.
引用
- Yılmaz UC, Kızılay DÖ, Kurt ÖK, et al. Autoantibody screening in children who are first-degree relatives of individuals with type 1 diabetes in a sibling-dominant cohort in Turkey: a multicentre study on prevalence, determinants and post-screening parent-child anxiety. Diabetologia. 2026. PMID: 42350669. doi:10.1007/s00125-026-06783-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。